Page 2,533«..1020..2,5322,5332,5342,535..2,5402,550..»

Crohn's and Colitis Specialist Dr. Amar Naik Joins Loyola University Health System

Posted: Published on February 23rd, 2015

Contact Information Available for logged-in reporters only Newswise Amar S. Naik, MD, a gastroenterologist who specializes in Crohns disease and ulcerative colitis, has joined Loyola University Health System. Dr. Naik earned his medical degree from the University of Illinois College of Medicine. He completed an internal medicine residency and fellowships in gastroenterology and hepatology at Medical College of Wisconsin, Milwaukee. He earned a bachelor of arts degree in psychology from the University of Illinois at Chicago. He joins Loyola from the Medical College of Wisconsin where he also served as assistant professor of medicine, Division of Gastroenterology & Hepatology. Dr. Naik is a member of several professional organizations, including The American Gastroenterological Association, Crohns & Colitis Foundation of America and the American Medical Association. As well as overseeing the clinical operation of Loyolas inflammatory bowel disease program, Dr. Naik has a strong interest in clinical research. He focuses on patient-oriented outcomes research with goals to improve long-term patient care and health-related quality of life. He is well-published in peer-reviewed journals, and has more than 50 abstracts accepted for presentation in numerous national and international workshops/conferences. I am happy to join a fine institution like Loyola that has a strong commitment … Continue reading

Posted in Ulcerative Colitis | Comments Off on Crohn's and Colitis Specialist Dr. Amar Naik Joins Loyola University Health System

Seizures and Epilepsy: Hope Through Research: National …

Posted: Published on February 23rd, 2015

Few experiences match the drama of a convulsive seizure. A person having a severe seizure may cry out, fall to the floor unconscious, twitch or move uncontrollably, drool, or even lose bladder control. Within minutes, the attack is over, and the person regains consciousness but is exhausted and dazed. This is the image most people have when they hear the word epilepsy. However, this type of seizure -- a generalized tonic-clonic seizure -- is only one kind of epilepsy. There are many other kinds, each with a different set of symptoms. Epilepsy was one of the first brain disorders to be described. It was mentioned in ancient Babylon more than 3,000 years ago. The strange behavior caused by some seizures has contributed through the ages to many superstitions and prejudices. The word epilepsy is derived from the Greek word for "attack." People once thought that those with epilepsy were being visited by demons or gods. However, in 400 B.C., the early physician Hippocrates suggested that epilepsy was a disorder of the brain -- and we now know that he was right. Epilepsy is a brain disorder in which clusters of nerve cells, or neurons, in the brain sometimes signal abnormally. … Continue reading

Comments Off on Seizures and Epilepsy: Hope Through Research: National …

Survey finds MS, epilepsy, cancer top targets for MN medical pot

Posted: Published on February 23rd, 2015

Multiple sclerosis, cancer and epilepsy are the top conditions Minnesotans hope to treat in the state's new medical marijuana program. An online, informal survey of 1,361 potential participants in the Minnesota Medical Cannabis program, found about half of potential users of medical cannabis reported their qualifying condition as multiple sclerosis or severe muscle spasms, the Minnesota Department of Health said Monday. Seventy percent of the Minnesotans responding to the survey said they were likely to register for the medial cannabis program, 24 percent indicated they may register. The program is expected to begin dispensing medical marijuana July 1. According to the department survey, the most common conditions eligible for medical cannabis among respondents were: Multiple sclerosis or severe muscle spasms, 51.5 percent Cancer, 17.6 percent Epilepsy or seizures, 17.5 percent Glaucoma, 10.8 percent Crohn's disease, 9.3 percent Read more from the original source: Survey finds MS, epilepsy, cancer top targets for MN medical pot … Continue reading

Comments Off on Survey finds MS, epilepsy, cancer top targets for MN medical pot

Ohio State University program helps adults with autism thrive

Posted: Published on February 23rd, 2015

The most recent statistics show 1 in 68 babies has autism. The U.S. spends $11.5 billion a year on education and treatment for kids with the disorder, but what happens when those kids grow into adults? Braden Gertz is an early childhood education specialist, and a swimming instructor. The 24-year-old is also living with autism. "It's hard living on your own because you don't know what to do for yourself," said Gertz. Dr. Christopher Hanks, a pediatric and internal medicine specialist at Ohio State University, says only about 10 to 15 percent of adults with autism are able to live independently like Braden. "There's really a small percentage that are thriving in the community, and the rest struggle, said Dr. Hanks. By 2030 the number of adults living with autism is expected to increase by nearly 700 percent, but many adults with the disorder have nowhere to turn when it comes to medical care. "As children, they had great care, but as they become adults there's just no one specifically trained to care for them," said Dr. Hanks. Adults with autism are more likely to suffer from anxiety, depression, seizures, high blood pressure, high cholesterol, obesity and diabetes, but they … Continue reading

Comments Off on Ohio State University program helps adults with autism thrive

FAU center helps parents of autistic children

Posted: Published on February 23rd, 2015

With autism spectrum rates soaring, Jack Scott wants to make sure there's early diagnosis and intervention for children as young as 2, usually boys. "If parents aren't alert to fussy behavior, these kids become an expert and a lot of it is behavioral not medical per se," said Scott, executive director of the Center for Autism and Related Disabilities at Florida Atlantic University. "We can teach parents the key strategies to deal with problem behavior. It doesn't go away, but it can be made better. If parents handle it altogether wrong, it just gets worse." First, tell people who you are. CARD is state funded. We received a little over $1 million to serve five counties from Palm Beach County north. We're part of FAU in the Department of Exceptional Student Education. We're headquartered in Boca Raton, but we have offices in Jupiter and Port St. Lucie. We serve 3,500 families. What disorders do you mostly address? Autism Spectrum Disorders (ASD), which includes Autistic Disorder, Asperger Syndrome. Also girls with Rett Syndrome, and Dual Sensory Impairment or Sensory Impairment with another disabling condition. What exactly do you offer? We provide direct assistance to people with autism and similar disabilities and … Continue reading

Comments Off on FAU center helps parents of autistic children

Anguish as Coventry grandfather is denied Parkinson's 'wonder-drug' on NHS

Posted: Published on February 23rd, 2015

A Coventry grandfather has been denied access to a so-called wonder drug that could help reverse the effects of years of damage that Parkinson's Disease has ravaged on his body. Edward Reilly, known to his friends as Eamonn, was diagnosed with the progressive disease 16 years ago. He has now been told the NHS will not pay for him to at least try the breakthrough drug Duodopa which could ease his symptoms. Duodopa which is only prescribed as a last resort treatment option where other medications have failed is said to help control involuntary movements, night-time symptoms and help curtail 'off' periods. But last year NHS England announced the drug would not be routinely available on the NHS, meaning doctors have to make long and bureaucratic applications on a case-by-case basis. At present Eamonn, from Eastern Green, suffers with near paralysis at night. His wife Carol said: He hardly moves after 8.30pm. He also has a lot of off time when he cant move his legs. The cost of treatment using Duodopa for one year would be 26,000. Duodopa is a last resort treatment for Eamonn who has been declared unsuitable for all other treatment, due to his poor balance … Continue reading

Posted in Parkinson's Treatment | Comments Off on Anguish as Coventry grandfather is denied Parkinson's 'wonder-drug' on NHS

Parkinson's disease grandad denied 'wonder drug' that could reverse years of damage on his body

Posted: Published on February 23rd, 2015

A Parkinson's disease sufferer has been denied access to a so-called wonder drug that could reverse the effects of years of damage on his body. Edward Reilly, known to his friends as Eamonn, was diagnosed with the progressive disease 16 years ago. The Coventry grandfather has now been told the NHS will not pay for him to at least try the breakthrough drug Duodopa which could ease his symptoms. Duodopa which is only prescribed as a last resort treatment option where other medications have failed is said to help control involuntary movements, night-time symptoms and help curtail 'off' periods. But last year NHS England announced the drug would not be routinely available on the NHS, meaning doctors have to make long and bureaucratic applications on a case-by-case basis. At present Eamonn, from Eastern Green, suffers with near paralysis at night, reports the Coventry Telegraph. Suffering: Eamonn and Carol with the letter from the NHS His wife Carol said: He hardly moves after 8.30pm. He also has a lot of off time when he cant move his legs. The cost of treatment using Duodopa for one year would be 26,000. Duodopa is a last resort treatment for Eamonn who has been … Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson's disease grandad denied 'wonder drug' that could reverse years of damage on his body

Peptides used to protect stroke victims from brain damage

Posted: Published on February 23rd, 2015

West Australian researchers have discovered a way to use peptides to protect stroke victims from brain damage, and say the breakthrough may reduce the risk of sustaining a serious disability from a stroke, especially for people living in remote Australia. Professor David Blacker, the medical director of the West Australian Neuroscience Research Institute, said it was an important development in stroke research. "In the rats that were given experimental peptides the volume of stroke damage was substantially smaller," he said. "If we can apply that to human models, the hope would be that critical bits of the brain will be less affected." The discovery is a big deal, especially for the 50,000 people who will have a stroke this year. "It's devastating and there have been surveys that reveal older people will fear surviving a stroke with a substantial disability; they will fear that more than actually dying," Professor Blacker said. Professor Blacker, who is also a neurologist at Perth's Sir Charles Gairdner Hospital, said most researchers had given up trying to find such a treatment. "At these stroke conferences just recently, people have been standing and applauding the speakers ... because we're so used to trials that have had … Continue reading

Posted in Brain Injury Treatment | Comments Off on Peptides used to protect stroke victims from brain damage

Woonona woman ticks off bucket list goal

Posted: Published on February 23rd, 2015

Feb. 23, 2015, 9:30 p.m. Woonona's Karen Davies used an MS Australia Go for Gold scholarship to check one item off her bucket list. Supporter: Karen Davies will be poolside at next month's University of Wollongong Mega Swim. Picture: ANDY ZAKELI Woonona's Karen Davies used an MS Australia Go for Gold scholarship to check one item off her bucket list. The scholarship - funded through the 24-Hour Mega Swim events - helped the former high school teacher make it to Canada in 2013 to participate in the centenary celebrations of the school she taught at in 1991. Next month the 59-year-old will be poolside at the University of Wollongong Mega Swim event to support participants as they raise funds for scholarships for others living with multiple sclerosis. "These scholarships allow people with MS to do something that they wouldn't be able to do otherwise," Ms Davies said. "I came to my disability later in life but many younger people diagnosed with MS have had to quit university in order to work out how to live with the disease, they've had to put off their studies and their dreams. "These scholarships have supported such people to get back to their education, … Continue reading

Posted in MS Treatment | Comments Off on Woonona woman ticks off bucket list goal

Opexa Therapeutics Reports Year End 2014 Financial Results and Provides Corporate Update

Posted: Published on February 23rd, 2015

2014 and early 2015 Operational Highlights: We are pleased with the productive year we had last year, one that was highlighted by completing enrollment in our landmark Abili-T Phase 2b clinical trial of Tcelna in Secondary Progressive MS patients and expanding our pipeline into a second autoimmune disease, said Neil K. Warma, Opexas President and Chief Executive Officer. The Abili-T trial in progressive MS is one that we believe could be an important step in advancing a therapy that has the potential to be the treatment of choice in this patient population that currently has access to very limited treatment options. We continue to treat patients in the trial and expect to report top line results in the second half of 2016. Additionally, with the initiation of preclinical development activities in our second indication, neuromyelitis optica, we believe we have demonstrated our ability to leverage our T-cell technology platform into other disease areas. We also believe the platform could be leveraged even further to other autoimmune diseases. Clinical Development Update Upcoming potential development and regulatory milestones include: Financial Results for the Year Ended December 31, 2014 For the year ended December 31, 2014, Opexa reported a net loss of $15.1 … Continue reading

Posted in MS Treatment | Comments Off on Opexa Therapeutics Reports Year End 2014 Financial Results and Provides Corporate Update

Page 2,533«..1020..2,5322,5332,5342,535..2,5402,550..»